Evidence map›Paper›PMID 40231287›Full record

ArticleAdvances in radiation oncology2025

Deep Learning-Based Heterogeneity Correction of the Homogeneous Dose Distribution for Single Brain Tumors in Gamma Knife Radiosurgery.

Sangyoon Lee, Shubhendu Mishra, Yoichi Watanabe

Abstract read
In one paragraph

Article in Advances in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sangyoon LeeDepartment of Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota.
Shubhendu MishraDepartment of Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota.
Yoichi WatanabeDepartment of Radiation Oncology, University of Minnesota Medical School, Minneapolis, Minnesota.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Heterogeneity correction is vital in radiation therapy treatment planning to ensure accurate dose delivery. Brain cancer stereotactic treatments, like Gamma Knife radiosurgery (GKRS), often rely on homogeneous water-based calculations despite the potential heterogeneity impact near bony structures. This study aims to develop a method for generating synthetic dose plans incorporating heterogeneity effects without additional computed tomography (CT) scans. Methods and Materials: Magnetic resonance imaging and CT images, TMR10-based, and convolution-based dose distributions were used from 100 retrospectively collected and 22 prospectively collected GKRS patients. A conditional Generative Adversarial Network was trained to translate TMR10 into synthetic convolution (sConv) doses. Results: The generated sConv dose demonstrated qualitative and quantitative similarity to the actual convolution (Conv) dose, showcasing better agreement of dose distributions and improved isodose volume similarity with the Conv dose in comparison to the TMR10 dose (γ pass rate; sConv dose, 92.43%; TMR10 dose, 74.18%. Prescription isodose dice; sConv dose, 91.7%; TMR10 dose, 89.7%). Skull-induced scatter and attenuation effects were accurately reflected in the sConv dose, indicating the usefulness of the new dose prediction model as an alternative to the time-consuming convolution dose calculations. Conclusions: Our deep learning approach offers a feasible solution for heterogeneity-corrected dose planning in GKRS, circumventing additional CT scans and lengthy calculation times. This method's effectiveness in preserving dose distribution characteristics in a heterogeneous medium while only requiring a homogeneous dose plan highlights its utility for including the process in the routine treatment planning workflows. Further refinement and validation with diverse patient cohorts can enhance its applicability and impact in clinical settings.

Identifiers

PMID40231287
PMCPMC11994306

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.